Key Event Details
Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non-Executive Independent Director of the Company, notwithstanding his attaining the age of 75 years.
Director Background and Appointment History
- Mr. Ashok Kumar Ramawat was originally appointed as a Non-Executive Independent Director with effect from 25th August, 2020
- He holds a Bachelor's Degree in Science
- Possesses 46 years of post-qualification experience with good exposure in the Pharmaceuticals Industry
- Is not related to any of the Directors or Key Managerial Personnel of the Company
- Is not debarred from holding the office of Director by virtue of any order of SEBI or any other regulatory/statutory authority
Approval Process and Status
- The Board of Directors approved the continuation based on the recommendation of the Nomination and Remuneration Committee
- The approval is subject to shareholder approval by way of Special Resolution at the ensuing 41st Annual General Meeting of the Company
- The decision is made pursuant to Regulation 17(1A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Meeting Details
The Board meeting commenced at 04:30 PM and concluded at 05:30 PM on 11th August, 2026.
Compliance and Filing Details
- Disclosure submitted in both PDF and XBRL format through the stock exchange filing utility
- Information will be made available on the company website at www.biofilgroup.net
- Compliance with BSE Circular No. LIST/COMP/14/2018-19 dated June 20, 2018 and NSE Circular No. NSE/CML/2018/24 dated June 20, 2018 confirmed